CORNING, N.Y., January 07, 2013 – Corning Incorporated (NYSE: GLW) today will introduce Corning® Gorilla® Glass 3 with Native Damage Resistance™ at the International Consumer Electronics Show (CES) in Las Vegas this ...
Tags: Corning, Glass, glass composition, Corning Gorilla Glass
Tranzyme Pharma has completed the chemistry-based drug discovery partnership and transferred the resulting compounds to Bristol-Myers Squibb to advance the development. The strategic collaboration leveraged Macrocyclic Template Chemistry, ...
Tags: Tranzyme Pharma, chemistry based drug, chemistry technology, company news
Scientists funded by Cancer Research UK are using virtual experiments in a bid to find the best methods for drug discovery. The findings have been published in the Nature Reviews Drug Discovery journal, with the work combining a unique ...
Tags: Cancer Research UK, virtual experiments, drug discovery, online database
Tecan and TAP Biosystems, a leading supplier of innovative cell culture systems, have announced a co-marketing agreement to further expand the automated 3D cell culture capabilities of the Freedom EVO® liquid handling platform. ...
Tags: Tecan and TAP Biosystems, innovative cell culture systems
NeRRe Therapeutics is established as a new drug discovery company for the development of a range of clinical and pre-clinical neurokinin antagonists separated from GlaxoSmithKline(GSK). The company,based at Stevenage Bioscience ...
Tags: NeRRe Therapeutics, GSK, pre-clinical neurokinin antagonists
Autodesk has entered into a collaboration agreement to develop a new software for Organovo's NovoGen MMX 3D bioprinter, designed for creating living human tissues that are three-dimensional. Three-dimensional human tissues or models are ...
Tags: Autodesk, software for Organovo's NovoGen MMX 3D bioprinter, Medicine
The Genome Institute of Singapore (GIS) and Fluidigm Corporation (FLDM) have established GIS-Fluidigm Single-Cell 'Omics Center (SCOC) to speed up the understanding of how individual cells work and how diagnosis and treatment might be ...
HTG Molecular Diagnostics has obtained ISO 13485:2003 certification for the design, manufacture, and distribution of its patented qNPA technology-based products and services used in the analysis of gene expression. qNPA molecular ...
Tags: ISO Certification, analysis of gene expression, medical technology
German- based SynenTec has entered into a definitive agreement to acquire Roche's Cellavista business. The acquisition will enable Roche to focus its business, and guarantee future optimal support and development of the technology for ...
Tags: acquisition, technology developement, cooperation, medical service
Critical Outcome Technologies (COTI) has signed a drug discovery deal with an undisclosed pharmaceutical company to use its CHEMSAS drug discovery system for the identification of small molecules. COTI will look after the discovery, ...
Tags: COTI, new drug research, CHEMSAS
Specialty chemicals and biologics supplier SAFC has inked an agreement with CrystalGenomics to develop active pharmaceutical ingredients (APIs) for non-steroidal anti-inflammatory drugs (NSAID). The agreement reflects SAFC's ...
Critical Outcome Technologies has received a patent for its advanced oncology drug candidate, from the US Patent and Trademark Office. The patent covers the synergistic effects of combination therapies containing COTI-2 and members of ...
Tags: oncology drug, COTI-2, anti cancer agents
Xybion's Pristima Preclinical Software suite has been selected for early-stage drug discovery pathology data management by a top-5 biotech firm. Pristima suite is the fully integrated preclinical and vivarium management solution that ...
Collaborative Drug Discovery (CDD) and SRI International have won a second grant from the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, for the joint development of an ...
Tags: Collaborative Drug Discovery, CDD, tuberculosis, TB
The Gulf Coast Consortia (GCC) for Quantitative Biomedical Sciences has entered into a five-year licensing agreement with Accelrys for scientific software, services and training. The investigators in the GCC Chemical Genomics (GCC-CG) ...
Tags: GCC, Gulf Coast Consortia, Quantitative Biomedical Sciences